Compare OCGN & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | NCMI |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 414.7M |
| IPO Year | 2014 | 2006 |
| Metric | OCGN | NCMI |
|---|---|---|
| Price | $2.31 | $3.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $7.00 | $5.90 |
| AVG Volume (30 Days) | ★ 5.1M | 539.3K |
| Earning Date | 06-08-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 3.55% |
| EPS Growth | 31.58 | ★ 52.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.13 |
| Revenue Next Year | $4,139.02 | $7.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $3.17 |
| 52 Week High | $2.00 | $6.18 |
| Indicator | OCGN | NCMI |
|---|---|---|
| Relative Strength Index (RSI) | 68.81 | 44.60 |
| Support Level | $1.44 | $3.17 |
| Resistance Level | N/A | $3.96 |
| Average True Range (ATR) | 0.16 | 0.19 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 85.67 | 26.32 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.